AI Guided Assessment of Heart Conditions
“Artificial intelligence (AI) has been developed for echocardiography1,2,3, although it has not yet been tested with blinding and randomization. Here we [researchers at Cedars-Sinai Medical Center, Los Angeles, CA] designed a blinded, randomized non-inferiority clinical trial . . . . of AI versus sonographer initial assessment of left ventricular ejection fraction (LVEF) to evaluate the impact of AI in the interpretation workflow. The primary end point was the change in the LVEF between initial AI or sonographer assessment and final cardiologist assessment, evaluated by the proportion of studies with substantial change (more than 5% change). From 3,769 echocardiographic studies screened, 274 studies were excluded owing to poor image quality.” MORE
Image Credit: David Ouyang, MD Twitter